Supplement: International Society for Pediatric and Adolescent Diabetes (ISPAD) Clinical Practice Consensus Guidelines 2018, 11-14 October 2018, Hyderabad, India. Guest Editor: David M. Maahs. Special Guest Editor: Mark Sperling. October 2018. Pages 28-46 Random plasma glucose of 11.1 mmol/L or more in the presence of symptoms or signs of diabetes. If the person is symptomatic, a single abnormal HbA1c or fasting plasma glucose level can be used, although repeat testing is sensible to confirm the diagnosis. Primary prevention for people with type 2 diabetes. atorvastatin 20 mg should be offered for the primary prevention of CVD to people with type 2 diabetes who have a 10% or greater 10-year risk of developing CVD. estimate the level of risk using the QRISK2 assessment tool. Donoghue, K.C., Marcovecchio, M.L., Wadwa, R.P. and Chew, E.Y. (2018) ISPAD clinical practice consensus guidelines 2018: microvascular and macrovascular complications in children and adolescents. Paediatric Diabetes 19(S27), 262-274. [ Abstract] Down, S. (2020) How to advise on sick day rules. Diabetes and Primary Care 22(3), 47-48. diabetes team. As outcome comparisons through benchmarking and registries are implemented more widely in pediatric diabetes—it is anticipated that more guidance of regimens associated with better long-term prognosis will become available2.3 Insulin therapy started in 1922 using regular insulin before each Clinical guidelines have been defined as 'systematically developed statements which assist clinicians and patients in making decisions about appropriate treatment for specific conditions'. This clinical guideline concerns the management of diabetes and its complications from preconception to the postnatal period. It has been developed with the aim of providing guidance on: preconception Linda A. DiMeglio, Carlo L. Acerini, Ethel Codner, Maria E. Craig, Sabine E. Hofer, Kubendran Pillay and David M. Maahs This chapter sets a target hemoglobin A1c (HbA1c) of <53 mmol/mol (<7.0%) for children, adolescents, and young adults with diabetes who have access to comprehensive care. Recent NICE guidance recommends that GPs and other primary healthcare professionals use a validated computer-based risk-assessment tool, such as QDiabetes, to identify people on their practice register who may be at high risk of type 2 diabetes. The tool should use routinely available data from patients' electronic health records. The recommendations on initial information and advice are largely based on the National Institute for Health and Care Excellence (NICE) clinical guidelines Type 2 diabetes in adults: management [NICE, 2020a] and Hypertension in adults: diagnosis and management [NICE, 2019a], the joint European Society of Cardiology (ESC)/European Association for the Study of Diabetes (EASD) publication ESC Chapter 2: Stages of type 1 diabetes in children and adolescents Jenny J Couper, Michael J Haller, Carla J Greenbaum, Anette-Gabriele Ziegler, Diane K Wherrett, Mikael Knip, Maria E Craig . This chapter has been updated to classify type 1 diabetes as stages 1 , 2 and 3. This National Clinical Guideline is relevant to all healthcare professionals working in healthcare settings delivering care to people living with type 1 diabetes. Readers should note that sections of the guideline relating to the National Institute for Health and Care Excellence (NICE) contextualisation are denoted by a blue background and border. Downl